Financhill
Back

Morphic Holding Quote, Financials, Valuation and Earnings

Buy
65

MORF
Morphic Holding

Last Price:
31.56
Seasonality Move:
12.13%

7 Day Trial

ALL ACCESS PASS

$ 7

Morphic Holding Price Quote

$31.56
+3.09 (+10.85%)
(Updated: June 24, 2024 at 3:40 PM ET)

Morphic Holding Key Stats

Buy
65
Morphic Holding (MORF) is a Buy

Day range:
$27.52 - $29.23
52-week range:
$19.35 - $62.08
Dividend yield:
0%
P/E ratio:
0.00
P/S ratio:
19.16
P/B ratio:
2.15%

Volume:
1.9M
Avg. volume:
537.1K
1-year change:
-53.37%
Market cap:
$1.4B
Revenue:
$521K
EPS:
$-3.5

How Much Does Morphic Holding Make?

Data Unavailable

Is Morphic Holding Growing As A Company?

Data Unavailable

Morphic Holding Stock Price Performance

  • Did Morphic Holding Stock Go Up Last Month?
    Morphic Holding share price went down by -3.46% last month
  • Did MORF's Share Price Rise Over The Last Year?
    MORF share price fell by -53.37% over the past 1 year

What Is Morphic Holding 52-Week High & Low?

Morphic Holding Price To Free Cash Flow

Data Unavailable

Is It Risky To Buy Morphic Holding?

  • How Much Debt Does Morphic Holding Have?
    Total long term debt quarterly is $0
  • How Much Cash Does Morphic Holding Have?
    Cash and short term investments quarterly total is $658.8M
  • What Is Morphic Holding’s Book Value Per Share?
    Book value per share is 13.25

Is Morphic Holding Cash Flow Positive?

  • What Is MORF Cash Flow From Operations?
    Cash flow from operations (TTM) is -$127.2M
  • What Is Morphic Holding’s Cash Flow From Financing?
    Cash flow from financing (TTM) is $351.9M
  • What Is Morphic Holding’s Cash Flow From Investing?
    Cash flow from investing (TTM) is -$222M

Morphic Holding Return On Invested Capital

Data Unavailable

Morphic Holding Earnings Date & Stock Price

Morphic Holding Competitors

  • Who Are Morphic Holding's Competitors?
    Below is a list of companies who compete with Morphic Holding or are related in some way:
    • Alnylam Pharmaceuticals Inc (ALNY)
    • Cytokinetics Inc (CYTK)
    • Amicus Therapeutics Inc (FOLD)
    • Insmed Inc (INSM)
    • Madrigal Pharmaceuticals Inc (MDGL)

Morphic Holding Dividend Yield

Data Unavailable

Morphic Holding Analyst Estimates

YoY Growth Past Surprise
EPS: 0% 5.51%
Revenue: 0% 0%

Analyst Recommendations

Buy Recommendations: 6
Hold Recommendations: 2
Sell Recommendations: 0
Price Target: 56.00
Upside from Last Price: 96.7%

Major Shareholders

  • How many MORF shares are owned by institutional investors?
    77.6M MORF shares are owned by institutional investors
  • How many MORF shares are owned by insiders?
    5.1M MORF shares are owned by insiders